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Abstract
We describe a 3-year-old Hispanic male with cblC-type methylmalonic aciduria and homocystinuria
who presented to the emergency department with progressive tachypnea, vomiting, and edema
secondary to pulmonary embolism and cor pulmonale. With aggressive medical management, there
was complete resolution of right heart failure and pulmonary hypertension after 3 months. Pulmonary
embolism is rare in the pediatric population. Children with cblC-type methylmalonic aciduria and
homocystinuria may be at increased risk for thrombus formation and pulmonary embolism due to
chronic hyperhomocystinemia, a risk factor for thrombus formation in the adult population. Aspirin
therapy may be indicated in children with inborn errors of metabolism that predispose to
hyperhomocystinemia.
Introduction
CblC-type methylmalonic aciduria and homocystinuria
(cblC) is an inborn error of vitamin B12 (cobalamin)
metabolism. The disease is attributable to mutations in the
gene MMACHC located on chromosome 1 [1]. Abnorm-
alities in MMACHC’s product result in deficient intra-
cellular conversion of cobalamin into its two functional
forms:adenosylcobalamin(AdoCbl)andmethylcobalamin
(MeCbl) [1]. AdoCbl normally acts as a cofactor for the
mutase-dependant conversion of methylmalonyl-CoA into
succinyl-CoA in organic acid metabolism and MeCbl is the
cofactor for methionine synthase in the re-methylation of
homocysteine to methionine. Therefore, the molecular
defect incblCresultsinthe accumulationof methylmalonic
acid and homocysteine (Figure 1).
The clinical manifestations of cblC are heterogeneous,
but typically include neurologic, developmental, ophthal-
mologic and hematologic abnormalities. Although patients
with classic homocystinuria (cystathione beta-synthase
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mia are at high risk for thromboembolic events, no
thromboembolic events were reported in the largest case
series of 50 patients with cblC [2,3]. There is only one case
report describing an infant diagnosed post-mortem
with cblC and cor pulmonale due to thromboembolism
[4]. Successful medical management of cor pulmonale
in this patient population has not been previously
described.
Case presentation
We describe a full-term Hispanic, male infant transferred
to our neonatal intensive care unit for management of
hypotonia and an abnormal urinary methylmalonic
acid level. The serum homocysteine level was elevated
(279 micromol/L; normal range <15 micromol/L),
suggesting a disorder of cobalamin metabolism. The
diagnosis of cobalamin C type methylmalonic aciduria
and homocystinuria (cblC) was later confirmed through
molecular testing. While in the NICU, a heart murmur
was detected and an echocardiogram showed a bicom-
missural pulmonary valve without stenosis and normal
biventricular function. He was discharged from the
NICU on medical management including dietary protein
restriction and hydroxycobalamin injections. He did
not return for cardiac follow up during the first three
years of life.
At three years of age, he presented to our emergency
department with a one-week history of progressive
respiratory distress, vomiting and facial and lower extre-
mity swelling. The remainder of the medical history was
noncontributory. The family reported compliance with
betaine therapy, but hydroxycobalamin injections were
not being given.
In the emergency department, the vital signs were pulse
130 beats/min, blood pressure 100/70 mmHg, respiratory
rate 40 breaths/min and O2 saturation 86% while breath-
ing room air. His O2 saturation improved to 99% with 5 L
of oxygen by facemask. He appeared to be a small (14 kg,
25
th percentile), sick child in moderate respiratory distress
with significant perioral cyanosis. He had periorbital and
pretibial edema. His lungs had decreased air entry at the
bases, but no rales were audible. Cardiac examination
revealed a hyperdynamic precordium, regular rhythm,
normal S1 and a loud, single S2 with no murmurs. His
liver edge was palpable 8 cm below the right costal margin
and the spleen tip was palpable just below the left costal
margin. His distal extremities were cool with delayed
capillary refill of 3-4 seconds and pulses were 1+
bilaterally.
A chest radiograph showed cardiomegaly, a right lower
lobe infiltrate and a small right pleural effusion.
Figure 1. Schematic illustrating how the molecular defect in cblC results in the accumulation of methylmalonic acid and
homocysteine.
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CO2 14, BUN 42, creatinine 0.7, ALT 128, AST 247, LDH
818, d-dimer 4.34. His ABG was pH 7.33, pCO2 33, HCO3
17 and base deficit of −7.6. His total serum homocysteine
level was 181 micromol/L (normal <15 micromol/L). The
methylmalonicacidlevelinhisurinewas90micromol/mol
Cr (normal range <2 micromol/mol Cr). CBC showed mild
macrocytic anemia (hematocrit 31.2%, MCV 110.6 fL).
A 12-lead EKG showed sinus tachycardia, right axis
deviation and right ventricular hypertrophy. An echocar-
diogram showed severe pulmonary hypertension with
severe right ventricular dilation (Figure 2A), severe
tricuspid regurgitation, moderate pulmonary regurgita-
tion, mild mitral regurgitation and mildly depressed left
ventricular function with a shortening fraction of 24%.
The right ventricular pressure was estimated to be greater
than one-half of the systemic blood pressure by the
tricuspid regurgitant jet (Figure 3). The pulmonary artery
diastolic pressure was 35 mmHg above the right ven-
tricular end-diastolic pressure based on the pulmonary
regurgitant jet (Figure 4). Additionally, there was a small
pericardial effusion.
The diagnosis of cor pulmonale secondary to pulmonary
embolism was suspected. In the PICU, milrinone (0.5
mcg/kg/min), a heparin infusion (10 units/kg/hr) and
furosemide (1 mg/kg IV every 8 hours) were initiated.
Hydroxycobalamin (1 mg IM daily) was reinstituted and
betaine therapy was optimized at a dose of 12 grams/day
(850 mg/kg/day). Folic acid and pyridoxine were supple-
mented. A lung perfusion scan showed a large perfusion
defect in the right middle lobe, but the result was
indeterminate for pulmonary embolism due to poor
patient cooperation. Ultrasound of the distal inferior
vena cava as well as bilateral iliac, common femoral,
Figure 2. Parasternal short axis 2D echocardiographic
images. (A) At the time of admission there was severe right
ventricular (RV) dilation and evidence of RV hypertension
with marked interventricular septal (IVS) flattening in systole.
(B) At 2.5 month follow-up, the RV size is normal and there is
resolution of RV hypertension with no IVS flattening in systole.
Figure 3. Spectral Doppler interrogation of severe tricuspid
regurgitation showing a maximal instantaneous gradient of
48 mmHg. The right ventricular systolic pressure is estimated
at 48 mmHg plus the right atrial pressure (more than
one-half systemic pressure with systolic BP of 100 mmHg)
using the modified Bernoulli equation.
Figure 4. Spectral Doppler interrogation of the pulmonary
regurgitant jet showing the pulmonary artery diastolic
pressure to be elevated at 35 mmHg above the right
ventricular end diastolic pressure.
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evidence of deep vein thrombosis.
The patient tolerated the transition onto oral furosemide
and digoxin. Sildenafil was initiated and his dose was
increased to 5 mg (0.3 mg/kg/dose) PO every 8 hours. He
was kept on low-molecular weight heparin every 12 hours
for anticoagulation. Prior to discharge, an echocardiogram
showed no significant improvement in his pulmonary
hypertension, right heart function or degree of tricuspid
and pulmonary regurgitation.
Since discharge, he has had no recurrence of cardiovas-
cular symptoms. A repeat echocardiogram 2.5 months
after discharge showed complete resolution of pulmon-
ary hypertension with normal right ventricular size and
function (Figure 2B), trivial tricuspid, mitral and pul-
monary regurgitation and qualitatively normal left
ventricular systolic function. His furosemide and digoxin
were discontinued at that time. Sildenafil was continued
for an additional 4 months and was weaned without
recurrence of pulmonary hypertension. He remains on
aspirin for anticoagulation and is followed regularly
by our Program for Inherited Metabolic Diseases
where his average total homocysteine level has been
67 micromol/L.
Discussion
Deep vein thrombosis and pulmonary emboli are uncom-
mon in pediatric patients [5]. A prospective Canadian
registry of venous thromboembolic events (VTE) in
children between the ages of 1 and 18 years showed the
incidence of pulmonary embolism to be 5.3/10,000
hospital admissions or 0.07/10,000 Canadian children
[6]. A prospective two-year registry of (VTE) in Dutch
children less than 18 years showed the incidence of VTE to
be 0.14/10,000 children [7]. Both studies found that more
than 95% of children with DVT and PE had at least one
associated condition predisposing them to thromboem-
bolism [6,7]. Patients with cblC may be predisposed to
thromboembolism because of the elevated homocysteine
levels associated with their disease. There are no studies
reporting on the relationship between hyperhomocystei-
nemia and thromboembolism in pediatric patients.
However, mild hyperhomocystinemia is an established
independent risk factor for myocardial infarction and
stroke in adults, events which are often triggered by
thromboembolism [8,9].
This is the first report of complete resolution of pulmonary
hypertension and right heart failure after aggressive
medical management in a patient with cblC. Since hyper-
homocysteinemia has been shown to be an independent
risk factor for thromboembolism in the adult population
[10], aspirin prophylaxis may be indicated to minimize
the risk of thromboembolism in pediatric patients with a
predisposition for hyperhomocysteinemia. This case also
underscores the importance of aggressively searching for
treatable underlying conditions that predispose to throm-
boembolic disease, such as the inborn errors of homo-
cysteine metabolism.
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